Will Acquiring Allergan Impact Pfizer's R&D?

Nov. 30 -- Dr. Beth Seidenberg, Kleiner Perkins Caufield & Byers general partner, discusses the financial implications of the Pfizer-Allergan deal. She speaks with Bloomberg's Emily Chang on "Bloomberg West."